Insulin-like growth factor-binding protein 7 is up-regulated during EAE and inhibits the differentiation of oligodendrocyte precursor cells

Biochemical and Biophysical Research Communications

Volumn 460, Issue 3, 2015, Pages 639-644

  Tan, Weixing ^a   Pu, Yingyan ^a   Shao, Qi ^a   Fang, Xue ^a   Han, Dunxin ^a   Zhao, Ming ^a   Cao, Li ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

EAE; Hes5; IGFBP 7; OPCs; Remyelination

Indexed keywords

INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-RELATED PROTEIN 1; PRIMER DNA; SOMATOMEDIN BINDING PROTEIN;

ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PATHOLOGY; UPREGULATION;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; DNA PRIMERS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MICE; MICE, INBRED C57BL; OLIGODENDROGLIA; UP-REGULATION;

EID: 84937760599     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.03.082     Document Type: Article

References (22)

1. K. Akaogi, J. Sato, Y. Okabe, Y. Sakamoto, H. Yasumitsu, and K. Miyazaki Synergistic growth stimulation of mouse fibroblasts by tumor-derived adhesion factor with insulin-like growth factors and insulin, cell growth & differentiation Mol. Biol. J. Am. Assoc. Cancer Res. 7 1996 1671 1677
2. S.S. Billiards, R.L. Haynes, R.D. Folkerth, N.S. Borenstein, F.L. Trachtenberg, D.H. Rowitch, K.L. Ligon, J.J. Volpe, and H.C. Kinney Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia Brain Pathol. 18 2008 153 163 (Zurich, Switzerland)
3. M.J. Carson, R.R. Behringer, R.L. Brinster, and F.A. McMorris Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice Neuron 10 1993 729 740
4. A. Compston, and A. Coles Multiple sclerosis Lancet 372 2008 1502 1517
5. D. Gveric, M.L. Cuzner, and J. Newcombe Insulin-like growth factors and binding proteins in multiple sclerosis plaques Neuropathology Appl. Neurobiol. 25 1999 215 225
6. V. Hwa, Y. Oh, and R.G. Rosenfeld The insulin-like growth factor-binding protein (IGFBP) superfamily Endocr. Rev. 20 1999 761 787
7. W. Jiang, C. Xiang, S. Cazacu, C. Brodie, and T. Mikkelsen Insulin-like growth factor binding protein 7 mediates glioma cell growth and migration Neoplasia 10 2008 1335 1342 (New York, N.Y.)
8. G.R. John, S.L. Shankar, B. Shafit-Zagardo, A. Massimi, S.C. Lee, C.S. Raine, and C.F. Brosnan Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation Nat. Med. 8 2002 1115 1121
9. E.H. Kolodny Dysmyelinating and demyelinating conditions in infancy Curr. Opin. Neurology Neurosurg. 6 1993 379 386
10. T. Kondo, and M. Raff Basic helix-loop-helix proteins and the timing of oligodendrocyte differentiation Development 127 2000 2989 2998 (Cambridge, England)
11. N.M. Kuhl, J. De Keyser, H. De Vries, and D. Hoekstra Insulin-like growth factor binding proteins-1 and -2 differentially inhibit rat oligodendrocyte precursor cell survival and differentiation in vitro J. Neurosci. Res. 69 2002 207 216
12. S. Mitew, C.M. Hay, H. Peckham, J. Xiao, M. Koenning, and B. Emery Mechanisms regulating the development of oligodendrocytes and central nervous system myelin Neuroscience 276 2014 29 47
13. T. Ohtsuka, M. Ishibashi, G. Gradwohl, S. Nakanishi, F. Guillemot, and R. Kageyama Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation EMBO J. 18 1999 2196 2207
14. C. Rupp, M. Scherzer, A. Rudisch, C. Unger, C. Haslinger, N. Schweifer, M. Artaker, H. Nivarthi, R. Moriggl, M. Hengstschlager, D. Kerjaschki, W. Sommergruber, H. Dolznig, and P. Garin-Chesa IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor-stroma interaction Oncogene 0 2014
15. C.C. Sprenger, S.E. Damon, V. Hwa, R.G. Rosenfeld, and S.R. Plymate Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer Cancer Res. 59 1999 2370 2375
16. C.E. Stewart, P.C. Bates, T.A. Calder, S.M. Woodall, and J.M. Pell Potentiation of insulin-like growth factor-I (IGF-I) activity by an antibody: supportive evidence for enhancement of IGF-I bioavailability in vivo by IGF binding proteins Endocrinology 133 1993 1462 1465
17. N.T. Villagra, J. Berciano, M. Altable, J. Navascues, I. Casafont, M. Lafarga, and M.T. Berciano PML bodies in reactive sensory ganglion neurons of the Guillain-Barre syndrome Neurobiol. Dis. 16 2004 158 168
18. N. Wajapeyee, R.W. Serra, X. Zhu, M. Mahalingam, and M.R. Green Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7 Cell 132 2008 363 374
19. G. Wolswijk Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis Brain 123 Pt 1 2000 105 115 a journal of neurology
20. Y. Wu, Y. Liu, E.M. Levine, and M.S. Rao Hes1 but not Hes5 regulates an astrocyte versus oligodendrocyte fate choice in glial restricted precursors Dev. Dyn. 226 2003 675 689 an official publication of the American Association of Anatomists
21. L. Xiao, D. Guo, C. Hu, W. Shen, L. Shan, C. Li, X. Liu, W. Yang, W. Zhang, and C. He Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination Glia 60 2012 1037 1052
22. M. Zeger, G. Popken, J. Zhang, S. Xuan, Q.R. Lu, M.H. Schwab, K.A. Nave, D. Rowitch, A.J. D'Ercole, and P. Ye Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination Glia 55 2007 400 411